Loading insider details...
Latest Form 4 (Nov 16, 2026): Grant/Award of 75,000 VIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 75,000 | n/a |
| Sep 25, 2026 | Theravance Biopharma, Inc. (TBPH) | Disposition to Issuer | 204,966 | n/a |
| Aug 24, 2026 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 8,112 | $137.5K |
| May 22, 2026 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 8,670 | $143.5K |
| Apr 3, 2026 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 37,500 | n/a |
| Feb 25, 2026 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 20,672 | $406.4K |
| Nov 24, 2025 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 18,627 | $333.4K |
| Aug 22, 2025 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 9,368 | $125.4K |
| May 22, 2025 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 9,348 | $88.3K |
| Mar 4, 2025 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 75,000 | n/a |